Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robot companion may soothe pain in dementia patients during care

NCT ID NCT03591822

Symptom relief Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether a social robot called PARO could help prevent pain during nursing care for elderly people with moderate to severe dementia. Ten participants living in nursing homes were given sessions with the PARO robot during care. The goal was to see if the robot could distract and relax patients, reducing signs of acute pain. The study also looked at effects on quality of life, medication use, and caregiver workload.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
PARO therapeutic robot (a social robot that responds to touch and sound)
What this could lead to
If it works, this could offer a drug-free way to ease pain and anxiety during daily care for people with dementia.
What could go wrong
This is a very small pilot study with only 10 participants, so results may not apply to everyone. The robot may not work for all patients or situations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

10 people

The number who actually took part.

Started

Feb 2019

Finished

Apr 2019

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient over 60 years of age * Consent to participate * Patient diagnosed by a geriatrician or a neurologist with moderate to severe dementia (MMSE\<24), according to the criteria of the Diagnostic and Statistical Manual DSM IV-TR (APA,2004) and NINCDS-ADRDA(McKhann et al.1984). * Patient living in a nursing home or a long stay department * Painful patient during nursing care (pain drugs prescription or direct observation) Exclusion Criteria: * Patient (or patient's legal representative) does not provide consent * The presence of acute organic disease or psychiatric decompensation and major neuropsychiatric symptoms incompatible with the intervention. * Patient who cannot interact physically with Paro * The presence of multidrug-resistant bacteria in patient to reduce the risk of contamination.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Moderate to severe dementia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

dementia Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Moderate to severe dementia

Contacts and locations

Locations

  • Hôpital Broca

    Paris, 75013, France

  • Résidence Mutualiste " L'adret "

    Bellegarde-en-Forez, 42210, France

  • Résidence Mutualiste " La Cerisaie "

    Saint-Etienne, 42000, France

  • Résidence Mutualiste " Les Tilleuls "

    La Grand-Croix, 43320, France

  • Résidence Mutualiste " Marie Lagrevol "

    Saint-Just-Malmont, 43240, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.